MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Change in Cash
$279K
Free Cash flow
-$1,689K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Proceeds from maturities of mark...
    • Other current assets
    • Noncash lease expense
    • Others
Negative Cash Flow Breakdown
    • Purchases of marketable securiti...
    • Dividends paid
    • Deferred revenue
    • Others
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income (loss)
-451
-154
-588
-431
Depreciation and amortization
23
11
22
28
Net accretion of marketable securities
-7
-29
-58
-103
Share-based compensation
0
0
29
35
Noncash lease expense
313
286
288
279
Deferred income taxes
0
0
-37
142
Inventories
70
-43
-113
-636
Other current assets
-415
57
-542
-280
Other assets
86
58
39
267
Accounts payable
-343
719
-455
49
Income taxes payable
-
-
-1
0
Accrued commissions
66
-268
203
-120
Other accrued expenses
-13
-263
-51
154
Deferred revenue
-796
-534
-432
-111
Amounts held in ewallets
-130
-80
-138
-137
Operating lease liabilities
-291
-294
-284
-297
Other current liabilities
6
-119
-73
-24
Net cash used in operating activities
-1,364
-797
-959
113
Purchases of property and equipment
325
115
5
43
Purchases of marketable securities
7,612
1,097
11,731
11,459
Proceeds from maturities of marketable securities
10,410
11,156
7,339
17,404
Net cash provided by investing activities
2,473
9,944
-4,397
5,902
Repurchase of common stock
0
5,870
-
-
Dividends paid
858
858
2,301
2,303
Net cash used in financing activities
-858
-6,728
-2,301
-2,303
Effect of exchange rates on cash, cash equivalents and restricted cash
28
-11
106
88
Net increase (decrease) in cash, cash equivalents and restricted cash
279
2,408
-7,551
3,800
Cash, cash equivalents and restricted cash, beginning of period
14,371
14,371
-
13,567
Cash, cash equivalents and restricted cash, end of period
9,507
9,228
-
14,371
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from maturitiesof marketable...$10,410K (-69.57%↓ Y/Y)Net cash provided byinvesting activities$2,473K (-62.77%↓ Y/Y)Effect of exchangerates on cash, cash...$28K (-76.27%↓ Y/Y)Canceled cashflow$7,937K Net increase(decrease) in cash, cash...$279K (109.31%↑ Y/Y)Canceled cashflow$2,222K Purchases of marketablesecurities$7,612K (-72.37%↓ Y/Y)Purchases of property andequipment$325K (1525.00%↑ Y/Y)Other current assets-$415K (-3.23%↓ Y/Y)Noncash lease expense$313K (-45.38%↓ Y/Y)Accrued commissions$66K (134.02%↑ Y/Y)Depreciation andamortization$23K (-61.02%↓ Y/Y)Other currentliabilities$6K (103.30%↑ Y/Y)Net cash used inoperating activities-$1,364K (73.52%↑ Y/Y)Net cash used infinancing activities-$858K (81.37%↑ Y/Y)Canceled cashflow$823K Deferred revenue-$796K (-155.95%↓ Y/Y)Net income (loss)-$451K (-429.20%↓ Y/Y)Accounts payable-$343K (-627.69%↓ Y/Y)Dividends paid$858K (-81.37%↓ Y/Y)Operating leaseliabilities-$291K (48.13%↑ Y/Y)Amounts held in ewallets-$130K (23.53%↑ Y/Y)Other assets$86K (-74.25%↓ Y/Y)Inventories$70K (113.33%↑ Y/Y)Other accruedexpenses-$13K (88.18%↑ Y/Y)Net accretion ofmarketable securities-$7K (96.73%↑ Y/Y)

NATURAL HEALTH TRENDS CORP (NHTC)

NATURAL HEALTH TRENDS CORP (NHTC)